Jingyun Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jingyun Tang has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Ehab Salah Eshak
Department of Public health and preventive medicine, Faculty of Medicine, Minia University
2 shared publications Jianxun Kang
Blood Research Laboratory Chengdu Blood Center Chengdu Sichuan China
2 shared publicationsMeng Li
Blood Research Laboratory Chengdu Blood Center Chengdu Sichuan China
2 shared publicationsXinman Du
Blood Research Laboratory Chengdu Blood Center Chengdu Sichuan China
2 shared publicationsXue Chen
Blood Research Laboratory Chengdu Blood Center Chengdu Sichuan China
2 shared publications- Xuemei Fu
Blood Research Laboratory, Chengdu Blood Center, Chengdu, Sichuan, China
2 shared publications
Latest Publications
- Open Access
- 28 April 2025
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 135 (1) , 82-88
Consumption of salt and high-salt foods and the risks of oral, pharyngeal and oesophageal cancers: the JACC Study
The association between salt and salted food consumption and oral, pharyngeal and oesophageal cancers remains inconclusive. To address this, we conducted a large-scale nationwide cohort study in Japan, a region globally recognised for its high-salt consumption. In a baseline survey conducted from 1988 to 1990, salt consumption was evaluated using a self-administered FFQ in a sample of 42 535 participants aged 40–79 years. Over a median 14·4-year follow-up period, 145 incident cases of oral ( n 43), pharyngeal ( n 17) and oesophageal ( n 85) cancers were observed. A Cox proportional hazards model was used to estimate the hazard ratio (HR) and 95 % CI after adjusting for age, sex, smoking status, alcohol consumption and fruit and vegetable consumption. High-salt consumption was associated with a higher risk of oral, pharyngeal and oesophageal cancers combined; the multivariable HR for the highest v . lowest tertiles of salt consumption was 1·67 (95 % CI: 1·08, 2·61, P -trend = 0·01). An excess risk was primarily observed for oral and oesophageal cancers. Among the salt sources, miso soup consumption was positively associated with the combined risk of oral, pharyngeal and oesophageal cancers; however, the consumption of other high-salt foods was not. In conclusion, high-salt consumption was associated with a higher combined risk of oral, pharyngeal and oesophageal cancers.
- 28 April 2025
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 135 (1) , 82-88
Open AccessConsumption of salt and high-salt foods and the risks of oral, pharyngeal and oesophageal cancers: the JACC Study
The association between salt and salted food consumption and oral, pharyngeal and oesophageal cancers remains inconclusive. To address this, we conducted a large-scale nationwide cohort study in Japan, a region globally recognised for its high-salt consumption. In a baseline survey conducted from 1988 to 1990, salt consumption was evaluated using a self-administered FFQ in a sample of 42 535 participants aged 40–79 years. Over a median 14·4-year follow-up period, 145 incident cases of oral ( n 43), pharyngeal ( n 17) and oesophageal ( n 85) cancers were observed. A Cox proportional hazards model was used to estimate the hazard ratio (HR) and 95 % CI after adjusting for age, sex, smoking status, alcohol consumption and fruit and vegetable consumption. High-salt consumption was associated with a higher risk of oral, pharyngeal and oesophageal cancers combined; the multivariable HR for the highest v . lowest tertiles of salt consumption was 1·67 (95 % CI: 1·08, 2·61, P -trend = 0·01). An excess risk was primarily observed for oral and oesophageal cancers. Among the salt sources, miso soup consumption was positively associated with the combined risk of oral, pharyngeal and oesophageal cancers; however, the consumption of other high-salt foods was not. In conclusion, high-salt consumption was associated with a higher combined risk of oral, pharyngeal and oesophageal cancers.
- 25 April 2024
- Published by Wiley in Transfusion
- Vol. 64 (6) , 1025-1039
Association between clinical symptoms during the COVID‐19 infection and SARS‐CoV‐2 immunoglobulin G titers in COVID‐19 convalescent whole‐blood donors in China
Background: Limited studies have explored the association between clinical symptoms and titers of SARS‐CoV‐2 antibodies.Study Design and Methods: In this cross‐sectional study, whole‐blood donors who had experienced a confirmed or suspected COVID‐19 infection completed questionnaires at the time of blood donation. Plasma SARS‐CoV‐2 immunoglobulin G (IgG) titers were measured using an enzyme‐linked immunosorbent assay. Logistic regression models were used to calculate odds ratios (ORs) for high‐titer COVID‐19 convalescent plasma (CCP) for each variable.Results: Among the total 386 donors, 120 (31%) donors with IgG titers ≥1:160 were classified as high‐titer donors. The multivariable ORs (95% confidence intervals [CIs]) for high titers were 2.33 (1.45–3.75), 2.11 (1.29–3.43), 1.10 (1.01–1.21), 1.19 (1.00–1.43), and 1.97 (1.05–3.71) for sore throat, cough, symptom count, fever duration, and low fever (compared with non‐fever), respectively. No significant association was observed between other symptoms and medical visits and the odds of high‐titer CCP. The association between high‐titer CCP and fever duration was restricted to confirmed COVID‐19‐infected donors, while associations with sore throat and cough remained significant in suspected infected donors. In addition, medical visit was positively associated with high‐titer CCP in suspected donors, but not in confirmed donors. In bootstrapped logistic regression models, the associations remained significant and reproducible for medical visit in suspected donors and for sore throat and cough in both suspected donors and total donors.Discussion: Experiencing a sore throat and cough were associated with high‐titer CCP in overall donors. We also identified sore throat, cough, and medical visits as potential predictors of high‐titer CCP for suspected donors during the pandemic.
- 25 April 2024
- Published by Wiley in Transfusion
- Vol. 64 (6) , 1025-1039
Association between clinical symptoms during the COVID‐19 infection and SARS‐CoV‐2 immunoglobulin G titers in COVID‐19 convalescent whole‐blood donors in China
Background: Limited studies have explored the association between clinical symptoms and titers of SARS‐CoV‐2 antibodies.Study Design and Methods: In this cross‐sectional study, whole‐blood donors who had experienced a confirmed or suspected COVID‐19 infection completed questionnaires at the time of blood donation. Plasma SARS‐CoV‐2 immunoglobulin G (IgG) titers were measured using an enzyme‐linked immunosorbent assay. Logistic regression models were used to calculate odds ratios (ORs) for high‐titer COVID‐19 convalescent plasma (CCP) for each variable.Results: Among the total 386 donors, 120 (31%) donors with IgG titers ≥1:160 were classified as high‐titer donors. The multivariable ORs (95% confidence intervals [CIs]) for high titers were 2.33 (1.45–3.75), 2.11 (1.29–3.43), 1.10 (1.01–1.21), 1.19 (1.00–1.43), and 1.97 (1.05–3.71) for sore throat, cough, symptom count, fever duration, and low fever (compared with non‐fever), respectively. No significant association was observed between other symptoms and medical visits and the odds of high‐titer CCP. The association between high‐titer CCP and fever duration was restricted to confirmed COVID‐19‐infected donors, while associations with sore throat and cough remained significant in suspected infected donors. In addition, medical visit was positively associated with high‐titer CCP in suspected donors, but not in confirmed donors. In bootstrapped logistic regression models, the associations remained significant and reproducible for medical visit in suspected donors and for sore throat and cough in both suspected donors and total donors.Discussion: Experiencing a sore throat and cough were associated with high‐titer CCP in overall donors. We also identified sore throat, cough, and medical visits as potential predictors of high‐titer CCP for suspected donors during the pandemic.
- 4 January 2024
- Published by Wiley in Transfusion
- Vol. 64 (2) , 367-379
Comparative analysis of the quality of platelet concentrates produced by apheresis procedures, platelet rich plasma, and buffy coat
Background: Platelet concentrates (PCs) could be prepared using either whole‐blood processes or apheresis instruments. During collection, processing and storage, some biochemical and functional changes occur, which may result in quality reduction. Quality evaluation of PCs may be helpful for the precise control of platelet (PLT) inventory to reduce the risk of refractoriness and adverse effects caused by platelet transfusion.Study Design and Methods: The study was aimed to evaluate the quality of PCs which were produced by five processes: apheresis (AP) procedures (using three different cell separators: Amicus, Trima Accel and MCS+ instruments), platelet rich plasma (PRP), and buffy coat (BC). A total of 100 PCs (20 of each group) were assessed in respect of routine quality control, morphology, size distribution, destroyed and activated platelets, and production of platelet‐derived microparticles (PMPs).Results: All PCs have satisfied the recommended quality of volume, platelet count, residual WBC count, residual RBC count, pH, and sterility according to the Chinese Technical Manual. There was no difference among the 5 groups in morphology and size of PLT and PMPs. Dynamic light scattering test showed that apheresis PCs showed peaks around 10–20 nm, but not whole blood‐derived PCs. PCs prepared by Amicus had the relatively high percentage of destroyed platelet, activated platelets and PMPs than other groups.Discussion: The data suggested high heterogeneity of PMPs, destroyed and activated platelets in PCs produced by different processes, which might be helpful to manage the platelet inventory for targeted use.
- 4 January 2024
- Published by Wiley in Transfusion
- Vol. 64 (2) , 367-379
Comparative analysis of the quality of platelet concentrates produced by apheresis procedures, platelet rich plasma, and buffy coat
Background: Platelet concentrates (PCs) could be prepared using either whole‐blood processes or apheresis instruments. During collection, processing and storage, some biochemical and functional changes occur, which may result in quality reduction. Quality evaluation of PCs may be helpful for the precise control of platelet (PLT) inventory to reduce the risk of refractoriness and adverse effects caused by platelet transfusion.Study Design and Methods: The study was aimed to evaluate the quality of PCs which were produced by five processes: apheresis (AP) procedures (using three different cell separators: Amicus, Trima Accel and MCS+ instruments), platelet rich plasma (PRP), and buffy coat (BC). A total of 100 PCs (20 of each group) were assessed in respect of routine quality control, morphology, size distribution, destroyed and activated platelets, and production of platelet‐derived microparticles (PMPs).Results: All PCs have satisfied the recommended quality of volume, platelet count, residual WBC count, residual RBC count, pH, and sterility according to the Chinese Technical Manual. There was no difference among the 5 groups in morphology and size of PLT and PMPs. Dynamic light scattering test showed that apheresis PCs showed peaks around 10–20 nm, but not whole blood‐derived PCs. PCs prepared by Amicus had the relatively high percentage of destroyed platelet, activated platelets and PMPs than other groups.Discussion: The data suggested high heterogeneity of PMPs, destroyed and activated platelets in PCs produced by different processes, which might be helpful to manage the platelet inventory for targeted use.
- Open Access
Supper Timing and Cardiovascular Mortality: The Japan Collaborative Cohort Study
Evidence on the role of supper timing in the development of cardiovascular disease (CVD) is limited. In this study, we examined the associations between supper timing and risks of mortality from stroke, coronary heart disease (CHD), and total CVD. A total of 28,625 males and 43,213 females, aged 40 to 79 years, free from CVD and cancers at baseline were involved in this study. Participants were divided into three groups: the early supper group (before 8:00 p.m.), the irregular supper group (time irregular), and the late supper group (after 8:00 p.m.). Cox proportional hazards regression models were used to calculate hazard ratios (HRs) for stroke, CHD, and total CVD according to the supper time groups. During the 19-year follow-up, we identified 4706 deaths from total CVD. Compared with the early supper group, the multivariable HR of hemorrhagic stroke mortality for the irregular supper group was 1.44 (95% confidence interval [CI]: 1.05–1.97). There was no significant association between supper timing and the risk of mortality from other types of stroke, CHD, and CVD. We found that adopting an irregular supper timing compared with having dinner before 8:00 p.m. was associated with an increased risk of hemorrhagic stroke mortality.
Open AccessSupper Timing and Cardiovascular Mortality: The Japan Collaborative Cohort Study
Evidence on the role of supper timing in the development of cardiovascular disease (CVD) is limited. In this study, we examined the associations between supper timing and risks of mortality from stroke, coronary heart disease (CHD), and total CVD. A total of 28,625 males and 43,213 females, aged 40 to 79 years, free from CVD and cancers at baseline were involved in this study. Participants were divided into three groups: the early supper group (before 8:00 p.m.), the irregular supper group (time irregular), and the late supper group (after 8:00 p.m.). Cox proportional hazards regression models were used to calculate hazard ratios (HRs) for stroke, CHD, and total CVD according to the supper time groups. During the 19-year follow-up, we identified 4706 deaths from total CVD. Compared with the early supper group, the multivariable HR of hemorrhagic stroke mortality for the irregular supper group was 1.44 (95% confidence interval [CI]: 1.05–1.97). There was no significant association between supper timing and the risk of mortality from other types of stroke, CHD, and CVD. We found that adopting an irregular supper timing compared with having dinner before 8:00 p.m. was associated with an increased risk of hemorrhagic stroke mortality.